BioNano Genomics Inc vs Tenet Healthcare Corporation — how do they compare? BioNano Genomics Inc trades at $1.2 (market cap $13.66M), while Tenet Healthcare Corporation trades at $259.45 (market cap $20.89B). The key difference: Tenet Healthcare Corporation is far larger — about 1529.3× BioNano Genomics Inc's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, BioNano Genomics Inc nearer its low. Which is the better fit depends on your goals.
| BNGO | THC | |
|---|---|---|
Market Cap | $13.66M | $20.89B |
Sector | Health | Health |
52-Week High | $4.92 | $262.63 |
52-Week Low | $1.06 | $161.37 |
Enterprise Value | $16.26M | $31.97B |
Trailing returns across standard periods
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →